RAYMOND JAMES & ASSOCIATES - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 26 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$138,625
+1.0%
140,0000.0%0.00%
Q4 2022$137,204
-40.6%
140,000
-41.7%
0.00%
Q3 2022$231,000
+0.4%
240,0000.0%0.00%
Q2 2022$230,000
+5.0%
240,0000.0%0.00%
Q1 2022$219,000
-3.1%
240,0000.0%0.00%
Q4 2021$226,000
-5.0%
240,000
-9.4%
0.00%
Q3 2021$238,0000.0%265,0000.0%0.00%
Q2 2021$238,000
-0.8%
265,000
-10.2%
0.00%
Q1 2021$240,000
+5.7%
295,0000.0%0.00%
Q4 2020$227,000
-50.4%
295,000
-48.2%
0.00%
-100.0%
Q3 2020$458,000
-5.0%
570,000
-10.9%
0.00%0.0%
Q2 2020$482,000
-7.3%
640,000
-1.5%
0.00%0.0%
Q1 2020$520,000
-21.8%
650,000
-1.5%
0.00%0.0%
Q4 2019$665,000
+14.5%
660,000
-2.2%
0.00%0.0%
Q3 2019$581,000
+837.1%
675,000
+864.3%
0.00%
Q2 2019$62,000
+26.5%
70,000
+40.0%
0.00%
Q1 2019$49,000
+6.5%
50,0000.0%0.00%
Q4 2018$46,000
-9.8%
50,0000.0%0.00%
Q3 2018$51,00050,0000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 5,324,000$4,995,0003.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 57,791,000$53,020,0002.12%
DLD Asset Management, LP 32,500,000$30,048,0002.06%
Castle Creek Arbitrage, LLC 4,504,000$4,161,0001.43%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$9,372,0000.62%
Graham Capital Management, L.P. 14,636,000$13,509,0000.60%
OAKTREE CAPITAL MANAGEMENT LP 64,452,000$59,704,0000.54%
Context Capital Management, LLC 1,000,000$926,0000.52%
ADVENT CAPITAL MANAGEMENT /DE/ 23,118,000$21,341,0000.52%
WOLVERINE ASSET MANAGEMENT LLC 18,583,000$17,322,0000.21%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders